ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients

Irinotecan is widely used in the treatment of metastatic colorectal cancer (mCRC) despite its severe toxicities. Toxicity is often associated with the UGT1A1*28/*28 genotype. An explanation for idiopathic toxicity beyond the UGT1A1 biomarker, however, remains a major concern for clinicians. One of t...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Pau Riera, Alícia Artigas-Baleri, Juliana Salazar, Ana Sebio, Anna C. Virgili, María Jesús Arranz, David Páez
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2020-06-01
Saila:	Frontiers in Pharmacology
Gaiak:	ABCB1 P-glycoprotein irinotecan (CPT-11) gastrointestinal toxicity diarrhea mucositis
Sarrera elektronikoa:	https://www.frontiersin.org/article/10.3389/fphar.2020.00973/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!